Happy New Year – 2016

It’s been an interesting year. When I started this site I really didn’t know what was going to happen… in most respects, it has exceeded my expectations. A Few Opening Remarks On a positive note, I genuinely felt support for the mission of trying to create a fresh dialogue around the quality and transparency of ASX-listed companies operating in this…

Phylogica : 600% Effective

Always good to get a pearl out of Phylogica (ASX : PYC) informing us that their latest “petri dish” experiment works 600% better than a previous “petri dish” experiment. Also nice to see approximately 600% abuse of ASX continuous disclosure rules… Instead of writing yet another rant about PYC’s rubbish in vitro studies, I am going to…

Starpharma Sensationalism – MkII

As a number of (slightly cocky and goading) readers pointed out today, my prior post on Starpharma’s utterly stupid pre-clinical announcement had a major flaw. In the interest of being comprehensive, I would like to make an additional follow-up comment, while simultaneously acknowledging my own incompetence and stupidity. I was too busy telling you about…

Starpharma Sensationalism

Really? REALLY? Yesterday Starpharma (ASX : SPL) announced that it had done some mouse models with a Herceptin-conjugated DEP dendrimer. It wasn’t peer reviewed data. It wasn’t an exhaustive pre-clinical package. It was just a one-off science experiment packaged up and served to retail investors as company propaganda. 20 mice. The company even states that…

ISN : iSonearlythere…

What a stupid company. I always thought it was beneath me to comment on this company, it’s truly that bad. But when I saw today’s ASX announcement about iSonea’s “second generation” wheeze monitor (a “Wheezometer” no less…), I just had to comment. Briefly. Not much more than a quick wheeze, I promise. Now, I don’t…

Keeping the flame alive…

Today, once again, Novogen announced that it has filed a couple of patents. Not received a notice of allowance or won an opposition or anything of commercial significance, but you know, just paperwork. Well done to Andrew Heaton and the team for getting some cunning new technology put down on the page – and especially a…